We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App





Olympus Highlights Surgical Visualization Platform for Future-Proof Endoscopic Surgery

By HospiMedica International staff writers
Posted on 31 Jan 2024
Print article
Image: The VISERA ELITE III surgical visualization platform (Photo courtesy of Olympus)
Image: The VISERA ELITE III surgical visualization platform (Photo courtesy of Olympus)

Olympus Corporation (Tokyo, Japan) is showing the latest innovations that redefine possibilities in healthcare, from state-of-the-art imaging technology to breakthrough medical procedures, at Arab Health 2024.

At the 49th edition of Arab Health, Olympus is showcasing, amongst others, its latest product launch, the VISERA ELITE III surgical visualization platform - an innovative and open solution that brings together multiple observation modes for future-proof endoscopic surgery. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as laparoscopic colectomy and laparoscopic cholecystectomy. By providing surgeons with multiple observation modes, the all-in-one system supports standardization and increases efficiency in the operating room. Users can also set up customized departmental profiles on VISERA ELITE III for different medical disciplines such as general surgery, urology, gynecology, ENT surgery, and more.

Olympus is also highlighting the POWERSEAL Sealer/Divider which supports the treatment of colon, stomach, lung, and other major types of cancer – but also non-cancer conditions – and can therefore be applied in various medical specialties, from lower to upper gastrointestinal surgery and gynecology, as well as in urology and other areas. Also being highlighted is the iTind, a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The temporarily implanted nitinol device is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind procedure aims to reshape the tissue of the prostatic urethra and the bladder neck. After 5-7 days, the iTind device is removed leaving nothing behind.

In addition, Olympus is showcasing the CELERIS disposable sinus debrider, a single-use microdebrider designed for ENTs who want the power and resection efficiency of a traditional sinus debrider in a convenient single-use solution, without compromising performance or quality. Within its medical portfolio, Olympus is showcasing its most advanced endoscopy system with AI, EVIS X1 which represents a range of new, easy-to-use technologies that aim to revolutionize the way gastrointestinal disorders can be detected, characterized, and treated.

Related Links:
Olympus Corporation

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Treatment Cart
Avalo Woodblend
New
Surgical Operating Lamp
OKM 600E

Print article

Channels

Critical Care

view channel
Image: The active substance TVEC led to a reduction in the size of the basal cell carcinoma in all study participants (Photo courtesy of 123RF)

Basal Cell Carcinoma Treatment Reduces Tumor Size, Improves Surgical Removal

Basal cell carcinomas, the most prevalent type of skin cancer, often appear in areas exposed to the sun, such as the face. Locally advanced tumors, in particular, present challenges for surgical treatment.... Read more

Surgical Techniques

view channel
Image: LumiSystem is the combination of two FDA approved products: LUMISIGHT (pegulicianine) and Lumicell Direct Visualization System (Photo courtesy of Lumicell)

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Breast cancer is the most frequently diagnosed cancer in women, with lumpectomies being the most common treatment approach. About 65% of women diagnosed with breast cancer undergo a lumpectomy, also referred... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
ARAB HEALTH 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.